PT Bundamedik Tbk (ISX:BMHS) Beta: 0.1331 (As of Jun. 28, 2026)


ISX:BMHS PT Bundamedik Tbk ISX:BMHS
61 GF Score
Price Rp182.00
GF Value Rp304.24
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk Beta?

PT Bundamedik Tbk ISX:BMHS +1.11% 61 Beta is 0.1331 as of Jun. 28, 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 61/100 and a GF Value™ of Rp304.24 (Possible Value Trap). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), PT Bundamedik Tbk's Beta is 0.1331.


PT Bundamedik Tbk  (ISX:BMHS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


PT Bundamedik Tbk Beta Related Terms


PT Bundamedik Tbk Beta Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk Beta Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial 0.00 0.00 0.00 -0.08 0.30

PT Bundamedik Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.29 0.20 0.11 0.30 0.18

ISX:BMHS vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, PT Bundamedik Tbk's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Bundamedik Tbk Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's Beta distribution charts can be found below:

* The bar in red indicates where PT Bundamedik Tbk's Beta falls into.


ISX:BMHS
61GF Score
PT Bundamedik Tbk ISX:BMHS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bundamedik Tbk Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.1331 mean?
PT Bundamedik Tbk (ISX:BMHS) has a Beta of 0.1331 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for PT Bundamedik Tbk and its competitors.
Is PT Bundamedik Tbk's Beta too high?
PT Bundamedik Tbk's current Beta is 0.1331. Overall, PT Bundamedik Tbk has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's Beta compare to HCA and THC?
PT Bundamedik Tbk's Beta of 0.1331 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for PT Bundamedik Tbk and its competitors. PT Bundamedik Tbk's current Beta is 0.1331. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp304.24, compared to a current price of Rp182.00 — trading 40.2% below its estimated fair value. The current Beta is 0.1331. PT Bundamedik Tbk's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current Beta is 0.1331 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp182.00 is trading 40.2% below its estimated GF Value™ of Rp304.24. GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.

Key valuation signals for ISX:BMHS:

  • Beta: 0.1331
  • GF Value™: Rp304.24 vs. price of Rp182.00 (40.2% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score

Get the complete analysis for ISX:BMHS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp182.00
Price
Rp304.24
GF Value